Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Le Shara M. Fulton"'
Autor:
Nicholas A. Taylor, James E. Bear, James M. Coghill, Matthew E. Berginski, Timothy P. Moran, Kaifeng Lisa Lin, Bruce R. Blazar, Michelle L. West, Jonathan S. Serody, Le Shara M. Fulton
Publikováno v:
Blood. 123:1604-1614
Graft-versus-host disease (GVHD) is a systemic inflammatory response due to the recognition of major histocompatibility complex disparity between donor and recipient after hematopoietic stem cell transplantation (HSCT). T-cell activation is critical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb581643cdd9e3fe8a9bf13427e1e73d
https://doi.org/10.1182/blood-2013-09-526020
https://doi.org/10.1182/blood-2013-09-526020
Autor:
Jonathan S. Serody, Angela Panoskaltsis-Mortari, Michelle L. West, Donald N. Cook, Kaifeng Lin, Benjamin G. Vincent, Le Shara M. Fulton, James M. Coghill, Bruce R. Blazar, Karen P. McKinnon, Kenneth A. Fowler, Hendrik W. van Deventer
Publikováno v:
Blood. 122:825-836
The infusion of donor regulatory T cells (Tregs) has been used to prevent acute graft-versus-host disease (GVHD) in mice and has shown promise in phase 1 clinical trials. Previous work suggested that early Treg migration into lymphoid tissue was impo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae23b5d11e4428a61ad0f668e911d86
https://doi.org/10.1182/blood-2012-06-435735
https://doi.org/10.1182/blood-2012-06-435735
Autor:
Dan R. Littman, Michelle L. West, Laura E. Ott, Michael J. Carlson, Bruce R. Blazar, Jonathan S. Serody, Angela Panoskaltsis-Mortari, James M. Coghill, Le Shara M. Fulton
Publikováno v:
The Journal of Immunology. 189:1765-1772
Graft-versus-host disease (GVHD) remains the most significant complication after allogeneic stem cell transplantation. Previously, acute GVHD had been considered to be mediated predominantly by Th1-polarized T cells. Recently, investigators have iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a37f2dcc44fe61596dc6c9ef4d7d4502
https://doi.org/10.4049/jimmunol.1200858
https://doi.org/10.4049/jimmunol.1200858
Autor:
Henrik Frydenlund Hansen, Maria A. Graziewicz, Jennifer Roberts, Ryszard Kole, Henrik Ørum, Peter Sazani, Brian K. Buckley, Le Shara M. Fulton, Teresa K. Tarrant
Publikováno v:
Molecular Therapy
Tumor necrosis factor-alpha (TNF-alpha) is a key mediator of inflammatory diseases, including rheumatoid arthritis (RA), and anti-TNF-alpha drugs such as etanercept are effective treatments. Splice-switching oligonucleotides (SSOs) are a new class of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c7071136e4fd4d6f9b2e8416b1a464
https://pubmed.ncbi.nlm.nih.gov/18461057
https://pubmed.ncbi.nlm.nih.gov/18461057